NCT04586582

Brief Summary

Clinical studies found that poor ST-segment resolution (STR) in electrocardiogram (ECG) occurred in major adverse cardiovascular events (MACE), arrhythmia and heart failure was significantly higher . In clinical work, in patients have poor ST-segment decline, the investigators found by CMR-LGE the corresponding myocardium become thinner and other signs of myocardial scar. The investigators aimed to establish whether poor ST-segment resolution in ECG, as well as CMR-LGE, could detect the presence of myocardial scar in early STEMI patients. In order to provide convenient, cheap and widely used test method for patients who cannot tolerate CMR-LGE. 42 STEMI patients with single-branch coronary artery stenosis or occlusion were enrolled. ST-segment elevations were measured on the baseline and 24 hours after PCI. The study population was divided into two groups by late gadolinium enhanced cardiac magnetic resonance (LGE- CMR), with transmural myocardial scar (\>75%) or non-transmural myocardial scar (\<75%).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

October 2, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 14, 2020

Completed
Last Updated

October 14, 2020

Status Verified

October 1, 2020

Enrollment Period

1.5 years

First QC Date

October 2, 2020

Last Update Submit

October 7, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • ST-segment resolution<40.15%

    CMR-LGE was performed to evaluate myocardial scars.

    1) Emergency admission: ST-segment elevations were measured. 2) 24 hours after PCI: ST-segment elevations were measured. 3) 7 days after PCI: CMR-LGE was performed.

  • ST-segment resolution>40.15%

    CMR-LGE was performed to evaluate myocardial scars.

    1) Emergency admission: ST-segment elevations were measured. 2) 24 hours after PCI: ST-segment elevations were measured. 3) 7 days after PCI: CMR-LGE was performed.

Study Arms (2)

ST-segment resolution <40.15%

ST-segment resolution \<40.15%

Diagnostic Test: ST-segment resolution <40.15%

ST-segment resolution >40.15%

ST-segment resolution \>40.15%

Diagnostic Test: ST-segment resolution <40.15%

Interventions

Forty-two STEMI patients with single-branch coronary artery stenosis or occlusion were enrolled. ST-segment elevations were measured at emergency admission and at 24 h after PCI. Late gadolinium-enhanced cardiac magnetic resonance imaging (CMR-LGE) was performed 7 days after PCI to evaluate myocardial scars.

ST-segment resolution <40.15%ST-segment resolution >40.15%

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

42 patients.

You may qualify if:

  • Single-branch coronary artery stenosis or occlusion
  • Restoration of coronary perfusion to TIMI flow grade 3 after PCI

You may not qualify if:

  • A prior history of the acute coronary syndrome
  • Coronary revascularization
  • Severe chronic kidney disease
  • Intracardiac pacing leads or other implants precluding CMR-LGE
  • Hemodynamic instability
  • Known claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The first affiliated hospital of Chongqing medical university

Chongqing, Chongqing Municipality, 400016, China

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Dongying Zhang, phD.

    First Affiliated Hospital of Chongqing Medical University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
2 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

October 2, 2020

First Posted

October 14, 2020

Study Start

July 1, 2017

Primary Completion

December 30, 2018

Study Completion

April 30, 2019

Last Updated

October 14, 2020

Record last verified: 2020-10

Locations